About Abgenics Life Sciences
Abgenics Life Sciences is a Healthcare company based in Pune (India) founded in 2010 by Anil Nahar. Drugs for intestinal worm infections are developed using Lactobacillus probiotics. Its Indian entity Abgenics Life Sciences Private Limited reported revenue of ₹4 Lakh. Abgenics Life Sciences offers products and services including AbTids®, Lactobacillus mediated delivery, Antibody Libraries, and CaMab-Drug Combinations. Its focus areas include Life Sciences, Microbiome Therapeutics, Probiotics and Genomics.
Company details
Abgenics Life Sciences was founded in 2010 in Pune, India, within the biotechnology sector. Focus is placed on creating therapeutic agents for helminth infections through probiotic strains of Lactobacillus. These strains are engineered to reside in the human gut and generate RNA molecules that target and disrupt specific parasite genes, leading to infection clearance. The approach is designed for sustained management of various worm infections.
- Headquarters Pune, India
- Founders Anil Nahar
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website abgenics.in
- Legal Name Abgenics Life Sciences Private Limited
- Date of Incorporation 01 Jun, 2010
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹4 Lakh
FY 2024 · +5614% YoY
- Net Loss-₹60.5 Lakh
FY 2024 · -1513% margin
- EBITDA-₹54.8 Lakh
FY 2024 · -1369% margin
- Latest Funding Round$100K (USD), Grant
Feb 2014
- Investors
Associated legal entities of Abgenics Life Sciences
Abgenics Life Sciences operates through Abgenics Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Abgenics Life Sciences Private Limited CIN U73100PN2010PTC136454 | Active | 01 Jun 2010 | Pune, Maharashtra | ₹0.0 Cr | 4 | View details |
Products & Services of Abgenics Life Sciences
Abgenics Life Sciences offers a comprehensive portfolio of products and services, including AbTids®, Lactobacillus mediated delivery, Antibody Libraries, and CaMab-Drug Combinations.
Fuses camelid antibodies with antimicrobial peptides for anti-infectives.
Delivers RNAi via Lactobacillus for targeted therapeutic applications.
Provides libraries of antibodies for research and disease detection.
Combines camelid antibodies with drugs for enhanced anti-cancer treatments.
Funding Insights of Abgenics Life Sciences
- Total Rounds 1
- Last Round Grant — $100,000
- First Round $100,000
(Feb 2014)
- Investors Count 1
All 1 funding rounds of Abgenics Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2014 | $100,000 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Abgenics Life Sciences
Abgenics Life Sciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Gates Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States |
Investor details for Abgenics Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Abgenics Life Sciences Private Limited (Abgenics Life Sciences)
Abgenics Life Sciences Private Limited is the primary company behind Abgenics Life Sciences. The board of Abgenics Life Sciences Private Limited currently have 4 directors; the longest-serving is Sunil Kantilal Nahar, appointed in 2010. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sunil Kantilal Nahar DIN 01180303 | Director | 01 Jun 2010 | 16 yrs 4 mo | Abgenics Life Sciences Private Limited |
| Sanjiban Kumar Banerjee DIN 02574706 | Director | 01 Jun 2010 | 16 yrs 4 mo | Abgenics Life Sciences Private Limited |
| Gaurav Anil Nahar DIN 02439378 | Managing Director | 13 Sep 2022 | 4 yrs 1 mo | Abgenics Life Sciences Private Limited |
| Darshan Sunil Nahar DIN 07033104 | Director | 01 Mar 2025 | 1 yr 8 mo | Abgenics Life Sciences Private Limited |
People of Abgenics Life Sciences
1 people are tracked at Abgenics Life Sciences (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership |
Complete people profiles for Abgenics Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Abgenics Life Sciences
Figures of Abgenics Life Sciences Private Limited, the primary company behind Abgenics Life Sciences, for FY 2024. Revenue was ₹4 Lakh (+5614% year on year). Net loss was -₹60.5 Lakh (-1513% margin). EBITDA was -₹54.8 Lakh (-1369% margin). Revenue has grown at a compounded annual rate of -18% over three years and -18% over five years.
- ₹4 LakhRevenue · FY 2024 · +5614% YoY
- -₹60.5 LakhNet loss · -1513% margin
- -₹54.8 LakhEBITDA · -1369% margin
- ₹1 LakhPaid-up capital
- -18%Revenue CAGR, 3 years
- -18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Abgenics Life Sciences Private Limited are on its company page.
Detailed financial statements for Abgenics Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Abgenics Life Sciences
2 dated milestones of Abgenics Life Sciences across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Abgenics Life Sciences is founded.
- Funding First funding round of $100K.
Web traffic of Abgenics Life Sciences
The website of Abgenics Life Sciences (abgenics.in) receives about 1.4K visits a month.
- Monthly visits1.4K
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Abgenics Life Sciences
Abgenics Life Sciences was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Abgenics Life Sciences is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
The primary company behind Abgenics Life Sciences, Abgenics Life Sciences Private Limited, reported revenue of ₹4 Lakh for FY 2024, up 5614% year on year.
Abgenics Life Sciences was founded in 2010 in Pune, India, within the biotechnology sector. Focus is placed on creating therapeutic agents for helminth infections through probiotic strains of Lactobacillus. These strains are engineered to reside in the human gut and generate RNA molecules that target and disrupt specific parasite genes, leading to infection clearance. The approach is designed for sustained management of various worm infections.
Abgenics Life Sciences offers AbTids®, Lactobacillus mediated delivery, Antibody Libraries, and CaMab-Drug Combinations.
Abgenics Life Sciences has 1 investor. Key investors include Gates Foundation.
Abgenics Life Sciences operates through Abgenics Life Sciences Private Limited.
The legal entities of Abgenics Life Sciences currently have 4 directors, including Gaurav Anil Nahar, Sunil Kantilal Nahar, Sanjiban Kumar Banerjee and others.